David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 67,271 shares at $13.03 ($877K) on 2022-06-02, disclosed to the SEC on 2022-06-06.
Open-market purchase of $877k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 1,129 | $15K | 1.7% |
| 2 | $13.03 | 33,071 | $431K | 49.2% |
| 3 | $13.03 | 33,071 | $431K | 49.2% |
| Total | $13.03 avg | 67,271 | $877K | 100% |
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |